- Home
- IGC vs NUKK Comparison
IGC vs NUKK Comparison
Compare IGC & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- NUKK
- Stock Information
- Founded
- IGC 2005
- NUKK 2013
- Country
- IGC United States
- NUKK United States
- Employees
- IGC N/A
- NUKK N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- NUKK Blank Checks
- Sector
- IGC Health Care
- NUKK Finance
- Exchange
- IGC Nasdaq
- NUKK Nasdaq
- Market Cap
- IGC 33.5M
- NUKK 29.4M
- IPO Year
- IGC N/A
- NUKK N/A
- Fundamental
- Price
- IGC $0.37
- NUKK $4.10
- Analyst Decision
- IGC Strong Buy
- NUKK
- Analyst Count
- IGC 2
- NUKK 0
- Target Price
- IGC $3.88
- NUKK N/A
- AVG Volume (30 Days)
- IGC 862.4K
- NUKK 259.4K
- Earning Date
- IGC 08-14-2025
- NUKK 09-10-2025
- Dividend Yield
- IGC N/A
- NUKK N/A
- EPS Growth
- IGC N/A
- NUKK N/A
- EPS
- IGC N/A
- NUKK N/A
- Revenue
- IGC $1,327,000.00
- NUKK N/A
- Revenue This Year
- IGC $15.26
- NUKK N/A
- Revenue Next Year
- IGC $3.41
- NUKK N/A
- P/E Ratio
- IGC N/A
- NUKK N/A
- Revenue Growth
- IGC 24.95
- NUKK N/A
- 52 Week Low
- IGC $0.25
- NUKK $1.30
- 52 Week High
- IGC $0.48
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- IGC 57.43
- NUKK 24.13
- Support Level
- IGC $0.35
- NUKK $3.74
- Resistance Level
- IGC $0.37
- NUKK $4.59
- Average True Range (ATR)
- IGC 0.02
- NUKK 0.63
- MACD
- IGC -0.00
- NUKK -0.04
- Stochastic Oscillator
- IGC 79.80
- NUKK 8.82
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).